![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
United States | Publication | July 2022
The US Occupational Safety and Health Administration (“OSHA”) published a proposed rulemaking on June 29, 2022, to approve a new occupational safety and health plan for Massachusetts state and municipal employers and workers. Public comments and requests for a hearing must be submitted by August 1, 2022. Submit comments online at the federal eRulemaking portal.
Under the Occupational Safety and Health Act, state and local government entities are excluded from federal OSHA coverage. However, the Act permits a state to assume occupational safety and health responsibility under the state’s own plan, which must be approved by OSHA. A state may obtain federal approval if its OSHA plan is at least as effective as the federal program.
The Massachusetts plan would cover approximately 6,500 public sector employers and their 434,000 employees. Private sector and federal government workers in Massachusetts remain under federal OSHA’s jurisdiction.
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Since 2022, the Government of Canada has introduced three waves of amendments to the Competition Act (Act), making substantive changes to Canada’s competition laws, with the most recent amendments receiving royal assent on June 20, 2024.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023